BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38316462)

  • 1. Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.
    Boston RH; Guan R; Kalmar L; Beier S; Horner EC; Beristain-Covarrubias N; Yam-Puc JC; Pereyra Gerber P; Faria L; Kuroshchenkova A; Lindell AE; Blasche S; Correa-Noguera A; Elmer A; Saunders C; Bermperi A; Jose S; Kingston N; ; Grigoriadou S; Staples E; Buckland MS; Lear S; Matheson NJ; Benes V; Parkinson C; Thaventhiran JE; Patil KR
    Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38316462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination.
    Jiao J; Shen Y; Wang P; Zuo K; Yang X; Chen M; Dong Y; Li J
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):280. PubMed ID: 36336856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection.
    Shenoy S
    Inflamm Res; 2022 Jan; 71(1):13-26. PubMed ID: 34738147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Gut Microbiome Signatures Correlate with Immunogenicity of SARS-CoV-2 mRNA Vaccines.
    Daddi L; Dorsett Y; Geng T; Bokoliya S; Yuan H; Wang P; Xu W; Zhou Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV.
    Ray S; Narayanan A; Vesterbacka J; Blennow O; Chen P; Gao Y; Gabarrini G; Ljunggren HG; Buggert M; Manoharan L; Chen MS; Aleman S; Sönnerborg A; Nowak P
    NPJ Biofilms Microbiomes; 2023 Dec; 9(1):104. PubMed ID: 38123600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine.
    Tang B; Tang L; He W; Jiang X; Hu C; Li Y; Zhang Y; Pang K; Lei Y; Li S; Liu S; Wang S; Yang M; Li Z; Zhao F; Yang S
    Cell Rep Med; 2022 Oct; 3(10):100752. PubMed ID: 36228621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
    Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
    EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Core Gut Microbiome of the American Cockroach, Periplaneta americana, Is Stable and Resilient to Dietary Shifts.
    Tinker KA; Ottesen EA
    Appl Environ Microbiol; 2016 Nov; 82(22):6603-6610. PubMed ID: 27590811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events.
    Ng SC; Peng Y; Zhang L; Mok CK; Zhao S; Li A; Ching JY; Liu Y; Yan S; Chan DLS; Zhu J; Chen C; Fung AC; Wong KK; Hui DS; Chan FK; Tun HM
    Gut; 2022 Jun; 71(6):1106-1116. PubMed ID: 35140064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between gut microbiota and COVID-19 and its vaccines.
    Leung JSM
    World J Gastroenterol; 2022 Oct; 28(40):5801-5806. PubMed ID: 36353201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients.
    Sun Z; Song ZG; Liu C; Tan S; Lin S; Zhu J; Dai FH; Gao J; She JL; Mei Z; Lou T; Zheng JJ; Liu Y; He J; Zheng Y; Ding C; Qian F; Zheng Y; Chen YM
    BMC Med; 2022 Jan; 20(1):24. PubMed ID: 35045853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.
    Hong M; Lan T; Li Q; Li B; Yuan Y; Xu F; Wang W
    Gut Microbes; 2023; 15(1):2233146. PubMed ID: 37431857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the oral microbiome of individuals with a healthy oral environment following COVID-19 vaccination.
    Uehara O; Abiko Y; Nagasawa T; Morikawa T; Hiraki D; Harada F; Kawano Y; Toraya S; Matsuoka H; Paudel D; Shimizu S; Yoshida K; Asaka M; Furuichi Y; Miura H
    BMC Oral Health; 2022 Mar; 22(1):50. PubMed ID: 35241064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and Microbiome in the Modulation of Vaccine Efficacy.
    Kumar M; James MM; Kumawat M; Nabi B; Sharma P; Pal N; Shubham S; Tiwari RR; Sarma DK; Nagpal R
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
    Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
    Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
    Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.